Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Equipment Contamination | 2 | 2023 | 183 | 0.840 |
Why?
|
| Shock, Septic | 2 | 2019 | 774 | 0.780 |
Why?
|
| Encephalitis, Tick-Borne | 1 | 2022 | 45 | 0.760 |
Why?
|
| Encephalitis Viruses, Tick-Borne | 1 | 2022 | 48 | 0.750 |
Why?
|
| Bronchoscopy | 3 | 2023 | 909 | 0.730 |
Why?
|
| Liver Abscess, Amebic | 1 | 2020 | 19 | 0.690 |
Why?
|
| Fractures, Compression | 1 | 2021 | 132 | 0.650 |
Why?
|
| Measles virus | 1 | 2019 | 67 | 0.650 |
Why?
|
| Shiga Toxin | 1 | 2019 | 36 | 0.640 |
Why?
|
| Porphyrias | 1 | 2018 | 55 | 0.620 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 2019 | 105 | 0.620 |
Why?
|
| Photosensitivity Disorders | 1 | 2018 | 80 | 0.610 |
Why?
|
| Encephalitis | 1 | 2022 | 441 | 0.590 |
Why?
|
| Hepatitis | 1 | 2019 | 227 | 0.570 |
Why?
|
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2020 | 214 | 0.570 |
Why?
|
| Measles | 1 | 2019 | 180 | 0.560 |
Why?
|
| Peroxidase | 1 | 2020 | 606 | 0.560 |
Why?
|
| Cross Infection | 2 | 2023 | 1427 | 0.560 |
Why?
|
| Disease Outbreaks | 2 | 2023 | 1759 | 0.530 |
Why?
|
| Heme | 1 | 2018 | 316 | 0.530 |
Why?
|
| Public Policy | 1 | 2021 | 551 | 0.530 |
Why?
|
| Porphyrins | 1 | 2018 | 351 | 0.530 |
Why?
|
| Virus Diseases | 1 | 2022 | 718 | 0.510 |
Why?
|
| Influenza Vaccines | 1 | 2023 | 778 | 0.510 |
Why?
|
| Spinal Fractures | 1 | 2021 | 703 | 0.460 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2018 | 669 | 0.430 |
Why?
|
| Shock, Cardiogenic | 1 | 2019 | 704 | 0.430 |
Why?
|
| Immunoglobulin M | 1 | 2018 | 1528 | 0.420 |
Why?
|
| Fever | 2 | 2020 | 1603 | 0.420 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 1789 | 0.400 |
Why?
|
| Influenza, Human | 1 | 2023 | 1539 | 0.390 |
Why?
|
| Osteoporosis | 1 | 2021 | 1582 | 0.380 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2019 | 1736 | 0.350 |
Why?
|
| Weight Loss | 1 | 2020 | 2710 | 0.300 |
Why?
|
| Peptide Fragments | 1 | 2019 | 5125 | 0.270 |
Why?
|
| Bronchoscopes | 2 | 2023 | 61 | 0.260 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 3247 | 0.260 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3223 | 0.240 |
Why?
|
| Pandemics | 3 | 2021 | 8703 | 0.200 |
Why?
|
| Greece | 2 | 2020 | 340 | 0.200 |
Why?
|
| Immunization Schedule | 1 | 2023 | 228 | 0.200 |
Why?
|
| Disinfection | 1 | 2023 | 207 | 0.190 |
Why?
|
| Polyarteritis Nodosa | 1 | 2021 | 68 | 0.180 |
Why?
|
| Cyprus | 1 | 2021 | 96 | 0.180 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 7478 | 0.170 |
Why?
|
| Tuberculosis, Spinal | 1 | 2019 | 16 | 0.170 |
Why?
|
| Spondylitis | 1 | 2019 | 20 | 0.170 |
Why?
|
| Brucellosis | 1 | 2019 | 21 | 0.170 |
Why?
|
| Immunity, Herd | 1 | 2020 | 48 | 0.170 |
Why?
|
| Stomatitis, Aphthous | 1 | 2020 | 51 | 0.160 |
Why?
|
| Chondrocalcinosis | 1 | 2020 | 84 | 0.160 |
Why?
|
| Infectious Mononucleosis | 1 | 2019 | 133 | 0.160 |
Why?
|
| Shiga-Toxigenic Escherichia coli | 1 | 2019 | 24 | 0.160 |
Why?
|
| Escherichia coli O157 | 1 | 2019 | 53 | 0.160 |
Why?
|
| Uroporphyrins | 1 | 2018 | 4 | 0.160 |
Why?
|
| Behcet Syndrome | 1 | 2020 | 86 | 0.160 |
Why?
|
| Porphyria, Erythropoietic | 1 | 2018 | 10 | 0.160 |
Why?
|
| New England | 1 | 2022 | 1059 | 0.160 |
Why?
|
| Porphyria Cutanea Tarda | 1 | 2018 | 12 | 0.160 |
Why?
|
| Hemoptysis | 1 | 2020 | 150 | 0.160 |
Why?
|
| Protoporphyrins | 1 | 2018 | 167 | 0.150 |
Why?
|
| Granuloma | 1 | 2019 | 327 | 0.140 |
Why?
|
| Seasons | 1 | 2023 | 1524 | 0.140 |
Why?
|
| Forced Expiratory Volume | 1 | 2021 | 1828 | 0.130 |
Why?
|
| Escherichia coli Infections | 1 | 2019 | 519 | 0.120 |
Why?
|
| Herpesvirus 4, Human | 1 | 2019 | 1078 | 0.110 |
Why?
|
| Humans | 21 | 2023 | 765968 | 0.110 |
Why?
|
| Gout | 1 | 2020 | 620 | 0.110 |
Why?
|
| Meta-Analysis as Topic | 1 | 2018 | 1370 | 0.100 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2019 | 1971 | 0.100 |
Why?
|
| Vaccination | 1 | 2023 | 3426 | 0.090 |
Why?
|
| Respiratory Insufficiency | 1 | 2019 | 1240 | 0.090 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2023 | 2159 | 0.090 |
Why?
|
| Iron | 1 | 2018 | 1816 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2020 | 4209 | 0.070 |
Why?
|
| Ultrasonography | 1 | 2020 | 5993 | 0.070 |
Why?
|
| Lymph Nodes | 1 | 2018 | 3454 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2020 | 10383 | 0.060 |
Why?
|
| Health Care Costs | 1 | 2018 | 3242 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 14652 | 0.060 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3100 | 0.050 |
Why?
|
| Quality of Life | 1 | 2023 | 13462 | 0.050 |
Why?
|
| Lung | 1 | 2019 | 10033 | 0.040 |
Why?
|
| Calcium Pyrophosphate | 1 | 2020 | 55 | 0.040 |
Why?
|
| Diagnosis, Differential | 3 | 2020 | 12976 | 0.040 |
Why?
|
| Colchicine | 1 | 2020 | 256 | 0.040 |
Why?
|
| Prognosis | 1 | 2019 | 29922 | 0.040 |
Why?
|
| Pharyngitis | 1 | 2019 | 221 | 0.040 |
Why?
|
| Eyelid Diseases | 1 | 2019 | 155 | 0.040 |
Why?
|
| Lung Neoplasms | 2 | 2021 | 13451 | 0.030 |
Why?
|
| Middle Aged | 3 | 2020 | 223009 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 20659 | 0.030 |
Why?
|
| Adult | 3 | 2019 | 223044 | 0.030 |
Why?
|
| Mobility Limitation | 1 | 2019 | 408 | 0.030 |
Why?
|
| Edema | 1 | 2019 | 760 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2021 | 1574 | 0.030 |
Why?
|
| Male | 4 | 2020 | 363698 | 0.030 |
Why?
|
| Methotrexate | 1 | 2020 | 1722 | 0.030 |
Why?
|
| Bronchi | 1 | 2018 | 843 | 0.030 |
Why?
|
| Endosonography | 1 | 2018 | 626 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2019 | 65188 | 0.020 |
Why?
|
| Risk Factors | 1 | 2019 | 74840 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2021 | 6309 | 0.020 |
Why?
|
| Neutrophils | 1 | 2023 | 3776 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2018 | 2887 | 0.020 |
Why?
|
| Medical Oncology | 1 | 2021 | 2339 | 0.020 |
Why?
|
| Time Factors | 2 | 2020 | 40065 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2023 | 15880 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 5526 | 0.010 |
Why?
|
| Female | 2 | 2019 | 396112 | 0.010 |
Why?
|
| Depression | 1 | 2023 | 8237 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 11206 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 26318 | 0.010 |
Why?
|
| Child | 1 | 2020 | 80564 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 171117 | 0.000 |
Why?
|
Concepts
(115)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(25)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_